The Patterson Analysis

Mobilewalla plans to go public as Covariate via a SPAC, touting its vertical AI. But a troubled SPAC market and a history of data privacy issues loom large.

With a second Inc. 5000 nod and XPRIZE validation, AgelessRx is proving that aging well is more than a trend—it's a high-growth industrial sector.

Percona's new fixed-fee services challenge the costly uncertainty of traditional IT consulting, offering a faster, more predictable path to database health.

Neonode's Q2 report shows shrinking revenue and widening losses, but a massive jump in MultiSensing® license sales points to a deliberate, high-stakes bet on the automotive sector.

A new technique bypasses the pitch, asking buyers to let their own AI deliver the verdict. It's a radical bet on product truth in the age of AI.

Riskified reports its strongest growth in four years, raising its outlook. Our analysis digs past the headlines to the execution behind its AI platform.

Colb Asset SA is leveraging Switzerland's DLT Act to offer tokenized pre-IPO structured products, a move that could unlock billions in illiquid assets.

While the dry bulk market is strong, Pangaea's Q2 earnings reveal a model where specialized fleets and integrated logistics deliver superior, market-beating margins.

American Share Insurance's CEO succession is more than a new name. It's a strategic move reinforcing its unique model in a shifting financial landscape.

As threats to critical infrastructure grow, Crytica Security launches a novel solution that monitors device integrity from within, not from the network.

As drones become critical infrastructure, their reliance on fragile satellite signals is a major risk. A new class of rugged, anti-jamming antennas aims to fix that.

The hiring of a tech-fluent legal chief is more than a personnel move; it's a blueprint for how financial firms must navigate the AI regulatory frontier.

Health tech firm Iterative Health appoints Dr. Samin Sharma, aiming to bridge the gap between AI-driven trial protocols and real-world cardiology care.

Nykredit's massive DKK 42.9B bond auction is more than just refinancing; it's a key indicator of market health, shaping rates for investors and homeowners.

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

As SKYX Platforms preps its Q2 earnings call, investors look beyond the numbers to its patent moat, e-commerce engine, and leadership's execution strategy.

The new IBQT fund offers a pre-packaged equity and bitcoin portfolio, signaling a major step in mainstreaming digital assets for Canadian investors.

Q2 results show growth, but rising costs and heavy spending underscore the pressure on Granite Ridge to hit its 2027 free cash flow inflection point.

As Birchtech preps for its Q2 earnings, the market is watching. Its PFAS-fighting tech is promising, but can it fix a battered stock and prove its path to profit?

Priovant's Phase 3 trial for brepocitinib in cutaneous sarcoidosis isn't just about one disease. It's a key move in Roivant's playbook to build a rare disease powerhouse.